Expression Profile of S100A2 and its Clinicopathological Significance in Renal Cell CarcinomaTakayuki Sugiyama, Hideaki Miyake|Anticancer Research|2020Cited by 8
Assessments of therapeutic effects according to timings for combined therapy with axitinib and immune check point inhibitor in a mouse renal cell carcinoma modelHiromitsu Watanabe, Hideaki Miyake|Scientific Reports|2023Cited by 7
Molecular Mechanism Mediating Cytotoxic Activity of Cabazitaxel in Docetaxel-resistant Human Prostate Cancer CellsHiromitsu Watanabe, Hideaki Miyake|Anticancer Research|2021Cited by 6
Enhanced Sensitivity to NVP-BEZ235 by Inhibition of p62/SQSTM1 in Human Bladder Cancer KoTCC-1 Cells Both <i>In Vitro</i> and <i>In Vivo</i>Keita Tamura, Hideaki Miyake|In Vivo|2020Cited by 3